Cosmo Pharmaceuticals N.V. (CMOPF)

OTCMKTS · Delayed Price · Currency is USD

151.00

-4.00 (-2.58%)

At close: Feb 11, 2026

Revenue by Product

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Own Products	52.97M
Own Products Growth	-0.64%
Generic Products, Specialty Drugs and Related Services	14.58M
Generic Products, Specialty Drugs and Related Services Growth	10.49%
Royalties	11.87M
Royalties Growth	19.90%
Licence Fees, Up-front Fees and Milestones	8.83M
Licence Fees, Up-front Fees and Milestones Growth	-63.82%
Other	1.90M
Other Growth	13.68%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Italy	90.14M
Italy Growth	-12.03%